Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 17  •  04:00PM ET
34.83
Dollar change
+0.81
Percentage change
2.38
%
Category
Global or ExUS Equities - Industry Sector
Asset Type
Equities (Stocks)
Tags
Return% 1Y
34.68%
Total Holdings
63
Perf Week
6.51%
Sponsor
Franklin Templeton
ETF Type
Tags
Return% 3Y
4.26%
AUM
22.61M
Perf Month
8.31%
Fund Family
Bond Type
Tags
Return% 5Y
-4.19%
NAV/sh
Perf Quarter
-6.35%
Index
-
Average Maturity
Tags
Return% 10Y
52W High
38.17 -8.74%
Perf Half Y
5.14%
Index Weighting
Commodity Type
Tags
-
Return% SI
52W Low
24.94 39.67%
Perf YTD
-4.06%
Active/Passive
Quant Type
Tags
-
Flows% 1M
0.00%
Volatility
0.43% 0.43%
Perf Year
34.91%
ESG Type
Tags
-
Flows% 3M
9.00%
ATR (14)
0.58
Perf 3Y
11.69%
Dividend Type
Sector/Theme
Flows% YTD
9.00%
RSI (14)
60.09
Perf 5Y
-22.72%
Structure Type
Region
Flows% 1Y
Beta
1.06
Perf 10Y
-
Expense
0.50%
Growth/Value
SMA20
5.40%
Flows% 3Y
Rel Volume
4.65
Prev Close
34.02
Inverse/Leveraged
Market Cap
SMA50
3.75%
Flows% 5Y
Avg Volume
1.01K
Price
34.83
IPO
Feb 27, 2020
Option/Short
Yes / No
SMA200
5.16%
Trades
Volume
4,714
Change
2.38%
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.